Susquehanna International Group’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Buy
+66,100
New +$1.16M ﹤0.01% 6644
2025
Q3
Sell
-11,800
Closed -$168K 12755
2025
Q2
$168K Sell
11,800
-7,900
-40% -$125K ﹤0.01% 11381
2025
Q1
$256K Buy
+19,700
New +$298K ﹤0.01% 10424
2022
Q2
Sell
-21,200
Closed -$92K 13155
2022
Q1
$92K Sell
21,200
-800
-4% -$3.15K ﹤0.01% 11968
2021
Q4
$94K Sell
22,000
-10,700
-33% -$51.2K ﹤0.01% 12185
2021
Q3
$165K Sell
32,700
-1,500
-4% -$7.8K ﹤0.01% 11704
2021
Q2
$211K Buy
+34,200
New +$253K ﹤0.01% 11490

Other funds holding ETON

Susquehanna International Group's ETON Position: Q1 2026 in Review

Susquehanna International Group opened a new position in Eton Pharmaceutcials (ETON) in Q1 2026: 34,084 shares worth $841K. The stake represents ﹤0.01% of the portfolio and ranks #8345 among its holdings. This is a return to the name: Susquehanna International Group previously reported a position in ETON as recently as Q3 2025.

Susquehanna International Group first reported a position in ETON in Q3 2021 and has held it in 13 quarters since. The position peaked at $5.83M in Q1 2025. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Susquehanna International Group held 34,084 shares of Eton Pharmaceutcials worth $841K as of Q1 2026.
  • Eton Pharmaceutcials was a new Susquehanna International Group position in Q1 2026.
  • Eton Pharmaceutcials made up ﹤0.01% of Susquehanna International Group's portfolio in Q1 2026, its #8345 holding.
  • Susquehanna International Group first reported a position in Eton Pharmaceutcials in Q3 2021 and has held it in 13 quarters since.
  • Susquehanna International Group's Eton Pharmaceutcials position peaked at $5.83M in Q1 2025.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Susquehanna International Group's 13F filing for Q1 2026, filed 15 May 2026.